Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.
about
Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acidRoles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.Review: pathogenesis of gallstones.Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones.Effect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.Increased gall bladder volume in primary sclerosing cholangitis.Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteersEffects of octreotide on gallbladder pressure and myoelectric activity of Oddi sphincter in rabbits.Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients.Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile.Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects.
P2860
Q28368915-519F54D7-DD11-42A8-97CB-963B87C157ECQ28378941-AD9C4355-185B-48A7-9FD7-3A2D1F361999Q33973631-453EE0B8-5A56-470B-8B60-3860C222DB3BQ33973667-B1DBA958-A598-4E20-B9D0-3F624771F707Q34408333-CC075073-44FA-4994-BEBF-3308A8F0C466Q34410105-E2A37DBD-B1A1-4C7A-9A08-530616F08F9CQ35355172-C8456547-42AD-43F3-B88D-317F0AACC1ACQ35841392-9792B267-9FFE-4DA3-99F4-1FA50DD5CAEEQ36491813-AA517871-6E78-4401-AF42-7F4547CC0FEBQ37292997-146D5854-BE18-4FBE-96B6-23A5A44833F0Q43517060-8799998E-8768-4DE1-881B-F4DFB4BE0BFBQ43734581-8279F1E4-2FA0-4AB5-8FC7-77DB1650D53DQ51585370-AFC8242A-E4BA-432D-8708-F1519CBF1735
P2860
Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Postprandial gall bladder moti ...... eotide treatment in acromegaly
@nl
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@ast
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@en
type
label
Postprandial gall bladder moti ...... eotide treatment in acromegaly
@nl
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@ast
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@en
prefLabel
Postprandial gall bladder moti ...... eotide treatment in acromegaly
@nl
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@ast
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@en
P2093
P2860
P356
P1433
P1476
Postprandial gall bladder moti ...... otide treatment in acromegaly.
@en
P2093
Koppeschaar HP
de Bruin WI
van Berge Henegouwen GP
van Erpecum KJ
P2860
P304
P356
10.1136/GUT.34.6.808
P407
P577
1993-06-01T00:00:00Z